Back to Search
Start Over
Preclinical Pharmacology and Safety Studies of GalNAc-conjugated Antisense Oligonucleotides Targeting Human PCSK9.
- Source :
-
Atherosclerosis (Supplements) . Jun2018, Vol. 32, p143-143. 1p. - Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 15675688
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Atherosclerosis (Supplements)
- Publication Type :
- Academic Journal
- Accession number :
- 129975462
- Full Text :
- https://doi.org/10.1016/j.atherosclerosissup.2018.04.438